Testing effectiveness (Phase 2)Study completedNCT01081574
What this trial is testing
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
Who this might be right for
Allergic RhinoconjunctivitisChronic Urticaria
Faes Farma, S.A. 36